← Open Payments lookup

MARY AMEH: Open Payments

NPI 1063881274 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$864 in 28 payments from 11 companies in 2025. Trend: 2023 $1,022 · 2024 $349 · 2025 $864

Food & beverage: $864
CompanyPaymentsAmount
Alkermes, Inc.6$220
Janssen Pharmaceuticals, Inc6$212
Axsome Therapeutics, Inc.4$114
Neurocrine BioSciences, Inc.2$63
Takeda Pharmaceuticals U.S.A., Inc.2$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Teva Pharmaceuticals USA, Inc.1$42
E.R. Squibb & Sons, L.L.C.2$39
Lundbeck LLC1$30
Supernus Pharmaceuticals, Inc.1$27

Products named: ARISTADA, INVEGA SUSTENNA, Auvelity, INGREZZA, REXULTI, TRINTELLIX, CAPLYTA, UZEDY.

Industry payments across WA — which companies pay providers there.